One can even trigger a digestive disease which makes it hard to swallow. It's known as EOE - Eosinophilic Esophagitis. For more than 30 years, Mimi Martinez has put her heart and soul into ...

eosinophilic esophagitis or, less likely, a hypersecretory syndrome or a genotype that confers altered metabolism of PPIs. Refractory reflux syndromes associated with normal endoscopy findings are ...

such as eosinophilic esophagitis, which occurs in an estimated 10% to 15% of children undergoing upper endoscopy for GERD symptoms. [6,11] The diagnostic tests that are useful in the evaluation of ...

Eupraxia Pharmaceuticals (EPRX)announced additional positive clinical data from its RESOLVE Phase 1b/2a trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in ...

Are you looking for effective medications to treat 'Eosinophilic Esophagitis (EoE)'? This page serves as your comprehensive resource hub, featuring the latest medications, both generic and brand ...

All patients who were admitted under Gastroenterology Unit underwent endoscopy. Of these, food bolus had cleared in 35 (11%) patients. For the rest of the patients, the food bolus was impacted in ...

Food patch testing is especially useful for identifying triggers of eosinophilic esophagitis. Eosinophilic esophagitis causes an allergic reaction in your esophagus that makes it hard to swallow. To ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Eosinophilic esophagitis is an allergic condition in which eosinophils (white blood cells that play a role in the immune ...

The first innovation in LEAP introduces transnasal endoscopy. This procedure reduces the need for sedation, which is particularly beneficial for patients requiring repeated endoscopies for conditions ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...